oral azacitidine,venetoclax
roche,bms,abbvie
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'omniverse', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'venetoclax', 'oral aza']
congress | #eha2023 | poster shaun fleming, summarizes the phase ib omniverse trial. results suggest that a maximum tolerated dose of oral azacytidine 300mg qd 14d + venetoclax 400mg qd 28d has a manageable safety profile in patients with r/r aml. #leusm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm